Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease

Silke Appel-Cresswell*, Carles Vilarino-Guell, Mary Encarnacion, Holly Sherman, Irene Yu, Brinda Shah, David Weir, Christina Thompson, Chelsea Szu-Tu, Joanne Trinh, Jan O. Aasly, Alex Rajput, Ali H. Rajput, A. Jon Stoessl, Matthew J. Farrer

*Korrespondierende/r Autor/-in für diese Arbeit
354 Zitate (Scopus)

Abstract

Background: Alpha-synuclein plays a central role in the pathophysiology of Parkinson's disease. Three missense mutations in SNCA, the gene encoding alpha-synuclein, as well as genomic multiplications have been identified as causes for autosomal-dominantly inherited Parkinsonism. Methods: Here, we describe a novel missense mutation in exon 4 of SNCA encoding a H50Q substitution in a patient with dopa-responsive Parkinson's disease with a family history of parkinsonism and dementia. Results: The variant was not observed in public databases or identified in unrelated subjects. Conclusions: The substitution's evolutionary conservation and protein modeling provide additional support for pathogenicity as the amino acid perturbs the same amphipathic alpha helical structure as the previously described pathogenic mutations.

OriginalspracheEnglisch
ZeitschriftMovement Disorders
Jahrgang28
Ausgabenummer6
Seiten (von - bis)811-813
Seitenumfang3
ISSN0885-3185
DOIs
PublikationsstatusVeröffentlicht - 06.2013

Fingerprint

Untersuchen Sie die Forschungsthemen von „Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren